1WHO. Human infection with avian influenza A (H7N9) virus- updata[EB/OL]. [2013 - 11 25]. http://www, who. int/csr/ doff/2013 - 11 - 06/en/index. html.
2Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from human[J]. Nature, 2013, 501(7468): 551 -555.
3Shi Y, Zhang W, Wang F, et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses[J].Science, 2013, 342(6155): 243-247.
4WHO. Influenza at the human-animal interface [ R]. Geneva: WHO,2013 : 3-4.
5Chowell G, Ammon CE, Hengartner NW, et al. Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: assessing the effects of hypothetical interventions [J]. J Theor Biol, 2006, 241 (2):193 -204.
6Doyle A, Bonmarin I, Levy-Bruhl D, et al. Influenza pandemic preparedness in France: modeling the impact of interventions [J]. J Epidemiol Commun Health, 2006, 60(5) :399 -404.
7Longini IM, Halloran ME, Nizam A, et al. Containing pandemic influenza with antiviral agents[ J]. Am J Epidemiol, 2004, 159 (7) : 623 -633.
8Lipsitch M, Cohen T, Murray M, et al. Antiviral resistance and the control of pandemic influenza[J]. PLoS Med, 2007, 4( 1 ) : 111 -121.
9Alexander ME, Bowman C, Moghadas SM, et al. A vaccination model for transmission dynamics of influenza [ J ]. SIAM J Appl Dyn Syst, 2004, 3(4) : 503 -524.
10Nuno M, Chowell G, Gumel AB. Assessing the role of basic con- trol measures, antivirals and vaccine in curtailing pandemic in- fluenza: scenarios for the US, UK and the Netherlands[ Jl. J R Soc Interface, 2007, 4(14) : 505 - 521.
